Gregg Williams buys 387,044 shares of Second Sight Medical Products, Inc. (NASDAQ: EYES)
Second Sight Medical Products, Inc. (NASDAQ:EYES – Get Rating) director Gregg Williams acquired 387,044 shares of the company in a transaction that took place on Wednesday, May 18. The shares were acquired at an average price of $1.66 per share, for a total transaction of $642,493.04. Following completion of the transaction, the administrator now directly owns 10,277,853 shares of the company, valued at $17,061,235.98. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
NASDAQ:EYES traded down $0.15 on Friday, hitting $2.00. The stock had a trading volume of 603,013 shares, compared to an average trading volume of 486,634. The company’s fifty-day moving average is $1.47 and its two-hundred-day moving average is 1. $65. Second Sight Medical Products, Inc. has a 12-month low of $1.14 and a 12-month high of $7.64.
Second Sight Medical Products (NASDAQ:EYES – Get Rating) last reported results on Monday, March 28. The medical device company reported ($0.02) earnings per share (EPS) for the quarter.
Separately, StockNews.com upgraded shares of Second Sight Medical Products to a “sell” rating in a Wednesday, March 30, report.
A number of large investors have recently increased or reduced their stakes in the company. Bank of America Corp DE increased its holdings of Second Sight Medical Products shares by 497.5% during the 2nd quarter. Bank of America Corp DE now owns 9,237 shares of the medical device company worth $46,000 after acquiring 7,691 additional shares during the period. Goldman Sachs Group Inc. increased its holdings of Second Sight Medical Products shares by 37.6% during the 4th quarter. Goldman Sachs Group Inc. now owns 33,950 shares of the medical device company worth $55,000 after acquiring 9,272 additional shares during the period. LPL Financial LLC increased its equity stake in Second Sight Medical Products by 93.0% during the 4th quarter. LPL Financial LLC now owns 20,698 shares of the medical device company worth $34,000 after acquiring an additional 9,971 shares during the period. Two Sigma Advisers LP purchased a new position in shares of Second Sight Medical Products during Q3 for a value of approximately $44,000. Finally, Millennium Management LLC purchased a new stock position in Second Sight Medical Products during Q2 for a value of approximately $77,000. Institutional investors hold 9.09% of the company’s shares.
About Second Sight medical products (Get a rating)
Second Sight Medical Products, Inc. develops, manufactures and markets implantable vision prostheses intended to provide artificial vision to people who are blind. It develops technologies to treat the visually impaired population. The Company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, intended to provide useful artificial vision to people who are blind due to a variety of causes, including glaucoma, diabetic retinopathy, optic nerve damage or disease, and eye damage.
Receive daily news and reviews for Second Sight medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Second Sight Medical Products and related companies with MarketBeat.com’s FREE daily newsletter.